Respiratory Devices And Equipment (Diagnostic) Market Report 2026

Respiratory Devices And Equipment (Diagnostic) Market Overview

• Respiratory Devices And Equipment (Diagnostic) market size has reached to $8.36 billion in 2025 • Expected to grow to $13.29 billion in 2030 at a compound annual growth rate (CAGR) of 9.7% • Growth Driver: Growing Prevalence Of Respiratory Diseases Boosts Demand For Respiratory Devices And Equipment (Diagnostic) Market • Market Trend: Thermo Fisher Scientific Launches Advanced Solutions for Enhanced Respiratory Diagnostics • Asia-Pacific was the largest region in 2025 and North America is the fastest growing region.

What Is Covered Under Respiratory Devices And Equipment (Diagnostic) Market?

Respiratory devices and equipment (diagnostic) are used in the diagnosis of respiratory disorders such as asthma, cystic fibrosis, and chronic obstructive pulmonary disease. They are used to measure lung function and oxygen levels, aiding healthcare providers in evaluating and managing respiratory health. The main products of the respiratory devices and equipment (diagnostic) market are instruments and devices, assays, and reagents. The respiratory instruments and devices are used to diagnose respiratory disorders. The test type included is traditional diagnostic tests, mechanical tests, imaging tests, and molecular diagnostic tests that are used to diagnose chronic obstructive pulmonary disease, lung cancer, asthma, tuberculosis, and other diseases. These are used in hospital/clinical laboratories, physician offices, reference laboratories, and other end users.

What Is The Respiratory Devices And Equipment (Diagnostic) Market Growth Forecast?

The respiratory devices and equipment (diagnostic) market size is expected to see strong growth in the next few years. It will grow to $13.29 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to growing investments in respiratory disease diagnostics, increasing adoption of molecular and imaging-based tests, expansion of home-based diagnostic monitoring, rising focus on personalized respiratory care, continued innovation in diagnostic assay development. Major trends in the forecast period include increasing adoption of portable diagnostic respiratory devices, rising use of molecular diagnostic tests for respiratory diseases, growing integration of ai-based lung function analysis, expansion of point-of-care respiratory testing, enhanced focus on early disease detection.

Global Respiratory Devices And Equipment (Diagnostic) Market Segmentation

1) By Product: Instruments And Devices, Assays And Reagents 2) By Test Type: Traditional Diagnostic Tests, Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests 3) By Disease Type: Chronic Obstructive Pulmonary Disease, Lung Cancer, Asthma, Tuberculosis, Other Diseases 4) By End User: Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories, Other End Users Subsegments: 1) By Instruments And Devices: Spirometers, Pulse Oximeters, Peak Flow Meters, Capnographs, Respiratory Pressure Monitors, Portable Ventilators 2) By Assays And Reagents: Diagnostic Kits, Reagents For Respiratory Infections, Blood Gas Analysis Reagents, PCR Assays For Respiratory Pathogens

What Is The Driver Of The Respiratory Devices And Equipment (Diagnostic) Market?

The increasing prevalence of various respiratory diseases is expected to propel the growth of the respiratory devices and equipment (diagnostic) market going forward. Respiratory diseases are medical conditions that affect the lungs and airways, impairing normal breathing and oxygen exchange due to inflammation, infection, obstruction, or chronic structural damage. The increasing prevalence of various respiratory diseases is due to a growing global burden of conditions that progressively impair lung function and make populations more vulnerable to long-term respiratory complications. Respiratory devices and equipment support the management of respiratory diseases by improving airflow, enhancing oxygen delivery, and enabling more effective monitoring of lung function to stabilize patient health. For instance, in June 2025, according to World Health Organization, a Switzerland-based organization, 81.7 million people are living with a chronic respiratory diseases and 6.8 million are newly diagnosed each year. Therefore, the increasing prevalence of various respiratory diseases drives the respiratory devices and equipment (diagnostic) industry.

Key Players In The Global Respiratory Devices And Equipment (Diagnostic) Market

Major companies operating in the respiratory devices and equipment (diagnostic) market are ResMed Inc., Medtronic plc, Masimo Corporation, Fisher & Paykel Healthcare Limited, Koninklijke Philips N.V., Smiths Medical, GE Healthcare, Chart Industries Inc., Philips Healthcare, Becton Dickinson and Company (BD), Abbott Laboratories, Thermo Fisher Scientific Inc., Teleflex Incorporated, Invacare Corporation, Vyaire Medical Inc., Drägerwerk AG & Co. KGaA, Getinge AB, Dräger Medical GmbH, bioMérieux, Bio-Rad Laboratories Inc - Bio-Rad Laboratories Inc., Cosmed S.r.l., Seegene Inc., SDI Diagnostics, GlaxoSmithKline plc, Hillrom, Hamilton Medical AG, Medline Industries Inc., 3M Company, Air Liquide, Allied Healthcare Products Inc., Armstrong Medical, Bio-Med Devices Inc., Breas Medical AB, CAIRE Inc., DeVilbiss Healthcare, Nihon Kohden Corporation, O2 Concepts LLC

Global Respiratory Devices And Equipment (Diagnostic) Market Trends and Insights

Major companies operating in the respiratory devices and equipment (diagnostic) market are focused on developing advanced diagnostic solutions such as automated nucleic acid purification instruments and Applied Biosystems MagMAX Dx Viral/Pathogen NA Isolation Kit to enhance the accuracy and speed of viral detection. Automated nucleic acid purification instruments and the Applied Biosystems MagMAX Dx Viral/Pathogen NA Isolation Kit facilitate rapid and reliable extraction of viral genetic material for accurate diagnostic testing. For instance, in December 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, launched Sample Preparation Solutions for Respiratory Diagnostic Testing. The Thermo Scientific KingFisher Apex Dx automates the purification of up to 24 or 96 samples of DNA, RNA, protein, or cells, ensuring high-quality results for respiratory testing. It works in conjunction with the Applied Biosystems MagMAX Dx Viral/Pathogen NA Isolation Kit, offering a comprehensive solution for in vitro diagnostics. Featuring advanced data management and cybersecurity, the system supports seamless workflows from sample preparation to real-time PCR analysis, suitable for both research and diagnostic applications.

What Are Latest Mergers And Acquisitions In The Respiratory Devices And Equipment (Diagnostic) Market?

In May 2025, ResMed Inc., a U.S.-based leader in sleep, breathing, and home healthcare devices, acquired VirtuOx for an undisclosed amount. With this acquisition, ResMed aims to expand its virtual care and in home diagnostic capabilities, integrating VirtuOx’s at home testing services into its ecosystem to provide earlier diagnosis and a more connected care pathway. VirtuOx is a US-based company that offers a virtual testing platform for sleep-disordered breathing and other respiratory conditions.

Regional Outlook

Asia-Pacific was the largest region in the respiratory devices and equipment (diagnostic) market in 2025. North America was the second largest region in the respiratory devices and equipment (diagnostic) market. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Respiratory Devices And Equipment (Diagnostic) Market?

The respiratory devices and equipment (diagnostic) market consist of sales of spirometer, polysomnographs, and peak flow meters and monitoring devices are pulse oximeters, capnography, and gas analyzers that are used for diagnosis of respiratory diseases. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.